Page last updated: 2024-10-31

nabumetone and Coxarthrosis

nabumetone has been researched along with Coxarthrosis in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becvár, R1
Urbanová, Z1
Vlasáková, V1
Vítová, J1
Rybár, I1
Maldyk, H1
Filipowicz-Sosnowska, A1
Bernacka, K1
Mackiewicz, S1
Gömör, B1
Rojkovich, B1
Siro, B1
Bereczki, J1
Toth, K1
Sukenik, S1
Green, L1
Ehrenfeld, M1
Pavelka, K1

Trials

1 trial available for nabumetone and Coxarthrosis

ArticleYear
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard.
    Clinical rheumatology, 1999, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Dicl

1999